SCYNEXIS
(NASDAQ) SCYX
SCYNEXIS Financials at a Glance
Market Cap
$43.49MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$20.34M
Net Income (TTM)
-$24.52M
EPS (TTM)
-$3.58
P/E Ratio
-1.22
Dividend
$0.00
Beta (Volatility)
1.28 (Average)
Dividend
$0.00
Beta (Volatility)
1.28 (Average)
Price
$4.28
Volume
111,474.375
Open
$4.57
Price
$4.28
Volume
111,474.375
Open
$4.57
Previous Close
$4.38
Daily Range
$4.17 - $4.61
52-Week Range
$3.68 - $10.48
Estimated Earnings Date
Aug 12, 2026
Dividend
$0.00
Beta (Volatility)
1.28 (Average)
Price
$4.28
Volume
111,474.375
Open
$4.57
Previous Close
$4.38
Daily Range
$4.17 - $4.61
52-Week Range
$3.68 - $10.48
Estimated Earnings Date
Aug 12, 2026
SCYX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout SCYNEXIS
Industry
Pharmaceuticals
Sector
Health CareEmployees
18
CEO
David Angulo Gonzalez, MD
Website
www.scynexis.comHeadquarters
Jersey City, NJ 07302-6548, US
SCYX Financials
Key Financial Metrics (TTM)
Gross Margin
100.00%
Operating Margin
-119.86%
Net Income Margin
-120.51%
Return on Equity
-57.16%
Return on Capital
-31.18%
Return on Assets
-31.58%
Earnings Yield
-81.97%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$43.49MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
9.93M
Volume
111.47K
Avg. Volume
68.91K
Financials (TTM)
Gross Profit
$20.34M
Operating Income
-$24.38M
EBITDA
-$24.52M
Operating Cash Flow
-$5.92M
Capital Expenditure
$0.00
Free Cash Flow
-$5.92M
Cash & ST Invst.
$59.26M
Total Debt
$2.06M
SCYNEXIS Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$0.00
-100.0%
Gross Margin
0.00%
N/A
Market Cap
$43.49MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$2.42M
N/A
Employees
18
N/A
Net Income
-$21.30M
-295.1%
EBITDA
-$21.30M
-334.1%
Quarterly Fundamentals
Total Cash
$59.26M
+45.9%
Total Debt
$2.06M
-17.1%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$1.56M
-24.5%
Short Term Debt
$504.00K
+18.6%
Return on Assets
-31.58%
N/A
Return on Invested Capital
-39.50%
N/A
Free Cash Flow
-$8.10M
-8.5%
Operating Cash Flow
-$8.10M
-8.5%